Healthcare


 Botanix Joins ASX 300, Bolstering its Global Dermatology Ambitions

Botanix Joins ASX 300, Bolstering its Global Dermatology Ambitions

March 10, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Entry into S&P/ASX300,: Botanix Pharmaceuticals has secured a place in the S&P/ASX300 index, reflecting its growing presence in the pharmaceutical industry.,FDA-Approved Treatment,: Sofdra, an innovative gel for primary axillary hyperhidro...

 Health Kick Podcast: Imagion's Alternative Approach to Cancer Imaging

Health Kick Podcast: Imagion's Alternative Approach to Cancer Imaging

March 09, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Revolutionary Cancer Imaging,: Imagion Biosystems is enhancing non-invasive imaging solutions to improve accuracy in cancer detection.,Regulatory and Clinical Progress,: The company is preparing for the next phase of clinical trials and an...

 Cardiex Unveils Groundbreaking At-Home Heart Health Report

Cardiex Unveils Groundbreaking At-Home Heart Health Report

March 08, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Cardiex introduces a Cardiology Report in its CONNEQT app, offering clinical-grade insights into cardiovascular health.,The feature is designed to increase user engagement and expand the company's health data ecosystem.,With the new report...

 Lumos Diagnostics Holdings Limited's (ASX:LDX) Stock Price Falls by 29% Due to Subpar Performance

Lumos Diagnostics Holdings Limited's (ASX:LDX) Stock Price Falls by 29% Due to Subpar Performance

March 08, 2025 09:30 AM AEDT| By Team Kalkine Media

Highlights:,Lumos Diagnostics Holdings saw a sharp decrease in share price, reflecting market sentiment.,The company's price-to-sales ratio is lower than the industry average, indicating valuation differences.,Revenue growth presents mixed signals, w...

 NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Weak Performance is Resulting in a Low P/E Ratio

NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Weak Performance is Resulting in a Low P/E Ratio

March 08, 2025 09:30 AM AEDT| By Team Kalkine Media

Highlights,NeuroScientific Biopharmaceuticals (ASX:NSB) has a P/E ratio of 4.1x, considerably lower than the market average.,Impressive last year earnings growth might not meet long-term market expectations.,Market apprehensions are evident in the co...

 CSL Limited (ASX:CSL) is set to distribute a US$1.30 dividend in two days.

CSL Limited (ASX:CSL) is set to distribute a US$1.30 dividend in two days.

March 07, 2025 09:30 PM AEDT| By Team Kalkine Media

Highlights:,CSL Limited is approaching its ex-dividend date, an essential milestone for shareholders.,Dividend payments remain within sustainable payout ranges based on earnings and free cash flow.,Earnings and dividend growth have shown steady upwar...

 Microba Life Sciences Limited (ASX:MAP) Sees a 29% Drop in Shares Amidst Confidence Concerns

Microba Life Sciences Limited (ASX:MAP) Sees a 29% Drop in Shares Amidst Confidence Concerns

March 07, 2025 03:33 PM AEDT| By Team Kalkine Media

Highlights:,Recent price movements have counteracted previous gains, affecting overall market positioning.,The company's valuation remains elevated compared to industry benchmarks, raising discussions on its justification.,Future growth estimates ind...

 An Insider Has Recently Sold Shares of Alcidion Group

An Insider Has Recently Sold Shares of Alcidion Group

March 07, 2025 03:32 PM AEDT| By Team Kalkine Media

Highlights:,A key executive at Alcidion Group recently sold shares, drawing attention to insider movements.,Insider ownership remains significant, reflecting alignment with broader shareholder interests.,Share transactions have occurred at market val...

 SomnoMed (ASX:SOM) experienced a 12% decline this week, extending its losses over five years to 66%.

SomnoMed (ASX:SOM) experienced a 12% decline this week, extending its losses over five years to 66%.

March 07, 2025 03:30 PM AEDT| By Team Kalkine Media

Highlights:,SomnoMed Limited has recorded an increase in share value in recent months, following an extended period of market decline.,Revenue trends show consistent growth, though share price movements indicate changing market expectations.,Recent c...

 Today's Highlights on HotCopper: Polynovo's 'Media Speculation' and Insignia's Bidding War | March 7, 2025

Today's Highlights on HotCopper: Polynovo's 'Media Speculation' and Insignia's Bidding War | March 7, 2025

March 07, 2025 01:30 PM AEDT| By Team Kalkine Media

Highlights:,The ASX experienced a drop in early trade, marking a consecutive decline over multiple days.,Real Estate, IT, and Financials were among the most affected sectors, reflecting broader economic shifts.,Select companies, including Polynovo Li...

 Leadership Shake-Up at PolyNovo (ASX:PNV) Amid Governance Concerns

Leadership Shake-Up at PolyNovo (ASX:PNV) Amid Governance Concerns

March 07, 2025 11:52 AM AEDT| By Team Kalkine Media

Highlights,PolyNovo,(PNV) confirms discussions,regarding,the CEO’s departure.,Reports suggest governance concerns involving the,chairman,.,Legal advisors recommend board restructuring for stability.,PolyNovo (ASX:PNV), a company specializing in innov...

 ASX Health Sector Declines Amid Increasing Market Challenges

ASX Health Sector Declines Amid Increasing Market Challenges

March 07, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,ASX healthcare stocks face market volatility amid global geopolitical tensions.,Pro Medicus secures a $40 million deal with US-based LucidHealth, boosting its market potential.,Opthea awaits critical phase III trial results as shares decli...

 Cochlear (ASX:COH) is set to distribute a higher dividend this year, amounting to A$2.15.

Cochlear (ASX:COH) is set to distribute a higher dividend this year, amounting to A$2.15.

March 06, 2025 09:30 PM AEDT| By Team Kalkine Media

Highlights,Cochlear Limited (COH) set to raise its dividend to A$2.15 in April.,Dividend growth has been inconsistent with a notable cut in the last decade.,Stable earnings per share growth could support future increases.,Cochlear Limited (ASX:COH) h...

 Here's Why We Have Concerns About the Cash Burn Situation at Neurotech International (ASX:NTI)

Here's Why We Have Concerns About the Cash Burn Situation at Neurotech International (ASX:NTI)

March 06, 2025 05:37 PM AEDT| By Team Kalkine Media

Highlights,Understanding cash burn is crucial for Neurotech International Limited's (ASX:NTI) stability.,The company faces a short cash runway, necessitating financial adjustments.,Potential shareholder dilution may occur if cash reserves need bolste...

 Nova Eye Medical Limited's (ASX:EYE) 30% Stock Decline Could Present an Opportunity, but Careful Analysis Is Needed

Nova Eye Medical Limited's (ASX:EYE) 30% Stock Decline Could Present an Opportunity, but Careful Analysis Is Needed

March 06, 2025 05:34 PM AEDT| By Team Kalkine Media

Highlights,Recent share price decline sparks questions among shareholders.,Nova Eye Medical boasts strong revenue growth despite P/S ratio concerns.,Industry outlook exceeds forecasted growth, yet market sentiment remains wary.,Shareholders of Nova E...

 Opthea's (ASX:OPT) First Half 2025 Financial Overview

Opthea's (ASX:OPT) First Half 2025 Financial Overview

March 06, 2025 05:33 PM AEDT| By Team Kalkine Media

Highlights,Opthea reports increased net loss for H1 2025,Significant revenue growth predicted over the next three years,Stock shows short-term decline of 18%,Opthea Ltd. (ASX:OPT) has disclosed its financial results for the first half of 2025. The co...

 The largest shareholders in Paragon Care Limited (ASX:PGC), the insiders, might be disheartened by the recent 10% decline in stock value.

The largest shareholders in Paragon Care Limited (ASX:PGC), the insiders, might be disheartened by the recent 10% decline in stock value.

March 06, 2025 05:33 PM AEDT| By Team Kalkine Media

Highlights,Insiders hold significant control over Paragon Care Limited (PGC) with 69% ownership.,The top two shareholders account for 57% of the company's shares.,Institutional and general public ownerships also play key roles in the company's dynami...

 Fisher & Paykel Healthcare (ASX:FPH) Expands Growth Plans with Major Infrastructure Investment

Fisher & Paykel Healthcare (ASX:FPH) Expands Growth Plans with Major Infrastructure Investment

March 06, 2025 02:03 PM AEDT| By Team Kalkine Media

Highlights,Fisher & Paykel Healthcare (FPH) invests NZ$250 million in a new facility.,The expansion aims to support research, manufacturing, and distribution.,A long-term growth strategy includes a second New Zealand campus.,Fisher & Paykel Healthcar...

 Mesoblast (ASX:MSB) Sees Market Dip Following ASX 200 Inclusion

Mesoblast (ASX:MSB) Sees Market Dip Following ASX 200 Inclusion

March 06, 2025 01:38 PM AEDT| By Team Kalkine Media

Highlights,Mesoblast (MSB) slips over 5% despite ASX 200 inclusion,Stock experiences volatility after a massive 12-month surge,Company,maintains,strong long-term momentum in biotech space,Shares of Mesoblast (ASX:MSB) saw a decline of over 5% during...

 Fisher & Paykel Healthcare (ASX:FPH) Expands Auckland Campus with NZ$250M Construction Project

Fisher & Paykel Healthcare (ASX:FPH) Expands Auckland Campus with NZ$250M Construction Project

March 06, 2025 12:27 PM AEDT| By Team Kalkine Media

Highlights,Fisher & Paykel Healthcare (FPH),initiates,a NZ$250M expansion at its East,Tāmaki,campus.,The new facility will house research, manufacturing, and distribution operations.,Completion expected in 2027 to support future product innovation.,F...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.